JPRN-UMIN000005266尚未招募未知
Effects of thiazolidinedione and biguanide in groups divided according to diabetic pathophysiology - Effects of thiazolidinedione and biguanide in groups divided according to diabetic pathophysiology
Department of Metablic Medicine, Osaka University Hospital0 个研究点目标入组 60 人开始时间: 2011年3月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. heart failure 2. severe liver and/or renal dysfunction 3. heavy drinkers, infectious disease, around operation, pregnancy patients whom the doctor regarded as imapropriate for the subjects
研究者
相似试验
已完成
不适用
Effects of aminobisphosphonates and thiazides in patients with osteopenia / osteoporosis, hypercalciuria and recurring renal calcium lithiasisBone mineral density loss and renal calcium stonesMusculoskeletal DiseasesOther osteoporosisISRCTN70158709San Cecilio University Hospital (Spain)70
尚未招募
不适用
General Anesthesia intubation responseCTRI/2021/12/038529self
尚未招募
3 期
Effect of tizanidine on pain after cardiac surgeryIRCT20201220049774N1Mashhad University of Medical Sciences60
已完成
3 期
Comparing effect of tizanidine hydrochloride vs. placebo on muscle cramp in hemodialysis patientsmuscle cramp in hemodialysis patients.Cramp and spasm,Extracorporeal dialysisR25.2,Z49.IRCT201510251598N3Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences20
已完成
4 期
Comparison of The Effects of Thiazolidinediones(TZD), Sodium- Glucose Cotransporter 2 Inhibitors(SGLT2i) Alone and TZD / SGLT2i Combination Therapy on Non-alcoholic Fatty Liver Disease in Type 2 Diabetic Patients With Fatty LiverMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseDigestive System DiseaseLiver DiseasesMetabolic Dysfunction-Associated Steatotic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHypoglycemic AgentsPhysiological Effects of DrugsSodium-Glucose Cotransporter 2 InhibitorsPioglitazoneMolecular Mechanisms of Pharmacological ActionEmpagliflozinType 2 DiabetesThiazolidinedionesFatty LiverNCT03646292Yonsei University60